« Back to Record
Citation APA

Bell, K. J., Saad, S., Tillett, B. B., McGuire, H. H., Bordbar, S., Yap, Y. A., Nguyen, L. T., Wilkins, M. M., Corley, S., Brodie, S., Duong, S., Wright, C. C., Twigg, S., de St Groth, B. F., Harrison, L. L., Mackay, C. R., Gurzov, E. N., Hamilton-Williams, E. E., & Mariño, E. (2022). Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation. Microbiome, 10(1), 9. doi:10.1186/s40168-021-01193-9


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/340499

Bell, K. J., Saad, S., Tillett, B. B., McGuire, H. H., Bordbar, S., Yap, Y. A., Nguyen, L. T., Wilkins, M. M., Corley, S., Brodie, S., Duong, S., Wright, C. C., Twigg, S., de St Groth, B. F., Harrison, L. L., Mackay, C. R., Gurzov, E. N., Hamilton-Williams, E. E., & Mariño, E. (2022). Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation. Microbiome, 10(1), 9. doi:10.1186/s40168-021-01193-9